Cuptimize’s Hip Surgery Software Cleared by FDA

The FDA has granted 510(k) clearance for Cuptimize’s spinopelvic tilt analysis software, a solution that does not require computed tomography (CT) scans prior to hip surgery.

Based exclusively on X-ray technology, the software helps hip surgeons understand when patients have a problem with pelvic tilt, to determine cup placement and to indicate when to use dual mobility implants.

The software is now available to orthopedic surgeons in the U.S., the Belleair, Fla.-based company said.